Cord blood transplant offers new hope for rare EBV diseases
NCT ID NCT07381738
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a transplant of donated umbilical cord blood can help people aged 14 to 80 with serious diseases caused by the Epstein-Barr virus (EBV), such as certain lymphomas or chronic active EBV infection. The goal is to control the disease and improve survival, but lifelong monitoring or additional treatment may still be needed. About 80 participants will receive the transplant and be followed for side effects and response.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC ACTIVE EPSTEIN-BARR VIRUS INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Huadong hospital, Fudan university
RECRUITINGShanghai, Shanghai Municipality, 200040, China
-
Huashan Hospital, Fudan University
RECRUITINGShanghai, Shanghai Municipality, 200040, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.